CompChem-Database: details for selected entry

DB03253_p0 (3533)

FormulaC5H12N2
MW100.16
InChIKeyAUKXFNABVHIUAC-UHFFFAOYNA-N
Entry_Date2023-09-01
Net_Charge0
Number_Atoms19
Number_Heavy_Atoms7
Number_Rings1
Number_Bonds19
Rotat_Bonds1
Unbranched_Chain2
Chiral_Centers1
ONatoms2
HB_Donor2
HB_Acceptor0
OpenEye_HB_Donors3
OpenEye_HB_Acceptors2
Lipinski_HB_Donors2
Lipinski_HB_Acceptors2
Lipinski_Violations0
XLogP30
XLogP-0.27
logP0.7262
PSA38.05
MR33.4591
ABS0.55
Solubilityvery
AggregatorPass
PM7_Heat_of_Formation_kcal_per_mol2.78761
PM7_Total_Energy_ev-1148.43714
PM7_Electronic_Energy_ev-5559.43502
PM7_Dipole_Debye0.32801
PM7_Point_GroupC1
PM7_HOMO_Energy_ev-9.411
PM7_LUMO_Energy_ev2.872
PM7_COSMO_Area_square_ang147.61
PM7_COSMO_Volue_cubic_ang141.7
PM7_Electron_Affinity_ev-2.872
PM7_Ionization_Energy_ev9.411
PM7_Energy_Gap_ev12.283
PM7_Global_Hardness_ev6.1415
PM7_Global_Softness_ev0.16282667100871123
PM7_Chemical_Potential_ev-3.2695
PM7_Electronigativity_ev3.2695
PM7_Back_Donation_Energy_ev-1.535375
PM7_Electrophilicity_ev0.8702784539607588
OPENEYE_Name[(2~{S})-pyrrolidin-2-yl]methanamine
SMILESC1CC(NC1)CN
Canonical_SMILESNC[C@@H]1CCCN1
InChI1/C5H12N2/c6-4-5-2-1-3-7-5/h5,7H,1-4,6H2
InChI_3D1S/C5H12N2/c6-4-5-2-1-3-7-5/h5,7H,1-4,6H2/t5-/m0/s1
AuxInfo1/0/N:1,2,3,5,4,7,6/rA:19cCCCCCNNHHHHHHHHHHHH/rB:s1;s1;s2;s4;s3s4;s5;s1;s1;s2;s2;s3;s3;s4;s5;s5;s6;s7;s7;/rC:;1.0015,0,0;-.3065,.9518,0;1.3133,.9518,0;2.1899,2.4664,0;.5008,1.5426,0;2.6908,3.3319,0;.0518,-.4973,0;-.4893,-.1031,0;1.4904,-.1047,0;.9488,-.4972,0;-.7634,.7487,0;-.5571,1.3845,0;1.7697,.7476,0;2.6227,2.216,0;1.7572,2.7169,0;.5,2.0426,0;3.1908,3.3314,0;2.4413,3.7652,0;
DuplicatesDB03253_p0
mol2_Path/CCDB/DrugBank/Database/Compound-0000000000-0000049999/Compound-0000003250-0000003499/DB03253_p0.mol2
pdbqt_Path/CCDB/DrugBank/Database/Compound-0000000000-0000049999/Compound-0000003250-0000003499/DB03253_p0.pdbqt
sdf_Path/CCDB/DrugBank/Database/Compound-0000000000-0000049999/Compound-0000003250-0000003499/DB03253_p0.sdf